Seven Eight Capital »

Denali Therapeutics shares owned by Seven Eight Capital

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Seven Eight Capital from 13F filings

Historical chart of Seven Eight Capital investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Seven Eight Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Seven Eight Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $422k 21k 20.52

More positions owned by Seven Eight Capital

Paycom Software (PAYC)
Lyft Cl A Com (LYFT)
Spirit Aerosystems Hldgs Com Cl A (SPR)
Dick's Sporting Goods (DKS)
Core & Main Cl A (CNM)
Cardinal Health (CAH)
Equitable Holdings (EQH)
AmerisourceBergen (COR)
Best Buy (BBY)
Microsoft Corporation (MSFT)
Xcel Energy (XEL)
Palo Alto Networks (PANW)
Advanced Micro Devices (AMD)
Bunge Global Sa Com Shs (BG)
Mastercard Incorporated Cl A (MA)

View all positions for Seven Eight Capital

Top funds holding Denali Therapeutics

Baillie Gifford & Co
BlackRock
Vanguard Group
Wellington Management Company
Crestline Management
Baker Bros. Advisors
Geode Capital Management
Marshall Wace
Bank of New York Mellon
T. Rowe Price Associates
Credit Suisse
Citadel Advisors
Flagship Ventures Management
Federated Investors
Dimensional Fund Advisors

View all funds holding Denali Therapeutics